NJ Panel Refuses To Revive Fosamax 'Jaw Death' Suit
A New Jersey appeals court on Monday refused to revive the case of a woman who claimed Merck Sharp & Dohme Corp.'s osteoporosis drug Fosamax caused her to develop osteonecrosis of...To view the full article, register now.
Already a subscriber? Click here to view full article